HPC Biosciences Limited

BSE:535217 Stock Report

Market Cap: ₹4.1b

HPC Biosciences Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Tarun Chauhan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure13yrs
CEO ownership0.06%
Management average tenureno data
Board average tenure10.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Tarun Chauhan's remuneration changed compared to HPC Biosciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023n/an/a

₹211k

Dec 31 2022n/an/a

-₹3m

Sep 30 2022n/an/a

-₹6m

Jun 30 2022n/an/a

-₹6m

Mar 31 2022n/an/a

-₹5m

Dec 31 2021n/an/a

₹3m

Sep 30 2021n/an/a

₹11m

Jun 30 2021n/an/a

₹11m

Mar 31 2021₹99k₹99k

₹12m

Dec 31 2020n/an/a

₹8m

Sep 30 2020n/an/a

₹4m

Jun 30 2020n/an/a

₹4m

Mar 31 2020₹474k₹474k

₹3m

Dec 31 2019n/an/a

₹6m

Sep 30 2019n/an/a

₹8m

Jun 30 2019n/an/a

₹7m

Mar 31 2019₹426k₹426k

₹6m

Dec 31 2018n/an/a

₹2m

Sep 30 2018n/an/a

-₹2m

Jun 30 2018n/an/a

₹5k

Mar 31 2018₹336k₹336k

₹2m

Compensation vs Market: Insufficient data to establish whether Tarun's total compensation is reasonable compared to companies of similar size in the Indian market.

Compensation vs Earnings: Insufficient data to compare Tarun's compensation with company performance.


CEO

Tarun Chauhan (43 yo)

13yrs

Tenure

₹98,750

Compensation

Mr. Tarun Chauhan has been a Whole-Time Director of HPC Biosciences Limited since October 1, 2011. Mr. Chauhan is the Promoter of HPC Biosciences Limited. He is responsible for day to day affairs of HPC Bi...


Board Members

NamePositionTenureCompensationOwnership
Tarun Chauhan
Whole-Time Director13yrs₹98.75k0.058%
₹ 2.4m
Madhu Anand
Non Independent Non-Executive Director13yrsno data21.87%
₹ 896.3m
- Mumtaj
Independent Non-Executive Director8.6yrsno datano data
Kishori Gupta
Independent Non-Executive Director6.6yrsno datano data

10.8yrs

Average Tenure

49yo

Average Age

Experienced Board: 535217's board of directors are seasoned and experienced ( 10.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/26 07:57
End of Day Share Price 2024/07/29 00:00
Earnings2023/03/31
Annual Earnings2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

HPC Biosciences Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.